Objectives: The prevalence of generalized anxiety disorder (GAD) is supposed to decrease with age. Reasons suggested include that emotional control increases and that anxiety and worry are expressed differently in older adults. The aim of this study was to examine how the expression of anxiety and worry changes with age and how this influences diagnoses in current classification systems. Results: The prevalence of clinical anxiety, autonomic arousal, muscle tension, and irritability decreased with age, while that of worry and fatigue increased. Concentration difficulties and sleep disturbances remained stable. The prevalence of ICD10 GAD tended to decrease, while that of DSM5 GAD did not change with age. Core symptoms and diagnoses of GAD were related to lower GAF scores. However, in those with autonomic arousal and ICD10 GAD, GAF scores increased with age.
and that the expression of anxiety may change with age. 18 Few population studies have examined how individual symptoms associated with GAD change with increasing age.
Current diagnostic criteria for mental disorders, the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD), are constructed by grouping clusters of symptoms. Thus, age-related changes in these symptoms may influence the prevalence of GAD. The classification of GAD differs between the two main classification systems of psychiatric disorders, the DSM 5th edition (DSM5 GAD) 19 and the ICD 10th edition, Diagnostic criteria for research (ICD10 GAD). 20, 21 Both diagnostic classification systems include similar core symptoms, ie, anxiety and worry. One distinguishing feature is the presence of autonomic symptoms in ICD-10 and the absence of these in DSM-5. Instead DSM5
GAD is loaded towards worry. In a previous study, we found that the diagnostic overlap between GAD according to DSM-IV and ICD-10 was only about 50%, suggesting the presence of two different types of GAD. 22, 23 We aimed to examine how the expression of anxiety and worry changes with increasing age in representative samples of 70-to 85-year-olds from Gothenburg, Sweden. We hypothesized that the prevalence of autonomic arousal and worry would decrease with age. We also aimed to study how age influences the prevalence of DSM5 GAD and ICD10 GAD. Based on previous findings, we hypothesized that the prevalence of ICD10 GAD would decrease with age due to its high loading on autonomic arousal. 20 We expected that the prevalence of DSM5 GAD would remain stable or decrease marginally due to its focus on anticipatory anxiety and worry. 19 2 | METHOD
| Sample
The samples were derived from the Longitudinal Gerontological and Geriatric Population Studies (H70) (H85) in Gothenburg, Sweden 24 ( Figure 1 ). Participants were selected from the Swedish Population
Register, based on birth date, and included both persons living in private households and in institutions. Examinations took place at an outpatient clinic of Sahlgrenska University Hospital in Gothenburg,
and those who declined were offered home visits. After complete description of the study, written informed consent was obtained from all participants and/or their relatives. The study was approved by the Regional Ethical Review Board in Gothenburg.
| The H70 study
In 2000, 896 individuals born on pre-specified dates in 1930 and living in Gothenburg, Sweden, on September 1 were selected for a study on
FIGURE 1
The flowchart describes the samples and design of the study. Two cohorts born in 1930 (H70) and 1923 to 1924 (H85) were used. Sample extension, attrition, and response rates are described in detail for each examination. The study has a cross-sectional design and excluded individuals with dementia and missing data on relevant items
Key points
• GAD is common among older adults.
• The expression of anxiety and worry changes with age.
• Autonomic arousal symptoms decreases with age while worry-related symptoms remain unchanged. For this specific study, 56 were excluded because of dementia and three due to missing symptom ratings, leaving 603 individuals (239 men, 364 women).
| The H85 study
We also included a sample from the H85 study. 25 In 2009, 1013 85-year-olds born in 1923 to 1924 and living in Gothenburg were selected from the Swedish population register. Among those, 44 died or emigrated before they could be examined, and 25 could not take part for other reasons, leaving an effective sample of 944 individuals.
Among those, 571 accepted to take part in the psychiatric examination (response rate 60.5%). For this specific study, 125 were excluded due to dementia and 13 due to missing symptom ratings, leaving 433 individuals (169 men, 267 women).
| Psychiatric examination
The same instruments were used at all examinations. The semistructured psychiatric examination was performed by trained psychiatric research nurses, under the supervision of the last author, using the Comprehensive Psychopathological Rating Scale (CPRS), 26 which has good applicability and interrater reliability in older people, 27 and the Mini-International Neuropsychiatric Interview (MINI). 28 Mental and social functioning was assessed with the Global Assessment of Functioning (GAF) scale. 29 Information on hospital care during the last year was obtained from the Swedish Hospital Discharge Register, and information on mortality (until November 2014) was obtained from the Swedish Population Register.
| Symptoms and diagnoses
Definition of symptoms was based on information from self-reported and/or observed items. The symptoms should have been present during the last month. Items from CPRS were rated 0 to 1 = No symptom present, 2 to 3 = Subclinical symptoms, and 4 to 6 = Clinical symptoms. 26 The definition of subclinical symptoms was borderline pathological symptoms. All these persons controlled the final diagnoses. Diagnosis was based on selected items from the MINI and the CPRS (Supporting Information Appendices S1 and S2). Due to the nature of our study, we did not use hierarchical exclusion criteria. The ICD-10 symptom "dry mouth" is not covered by MINI or CPRS, but the question was included in the general examination. We had no questions regarding "exaggerated response to minor surprises," "feeling keyed up or on edge," and "difficulty breathing," which are included in ICD10 GAD.
Major depression was diagnosed according to the current classification system DSM-5. Minor depression was diagnosed according to DSM IV-TR criteria, 30 as it is not used in DSM-5. Dementia was diagnosed according to DSM-III-R, 31 as previously described, 32 and used for exclusion only. We used these criteria as it is the traditional diagnostic criteria for dementia in our population studies. This is in common with several other population studies with start points around 1990.
| Statistical methods
The study design was cross-sectional, measuring 1-month prevalence of GAD-associated symptoms according to ICD-10 and DSM-5, at ages 70, 75, 79, and 85. To analyze the effect of age, we used generalized estimating equation (GEE) models, 33 adjusting for repeated measurements with an exchangeable working correlation matrix structure and a robust estimator of the covariance matrix. For binary outcome variables, we used a logistic link function. Results were presented with odds ratio (OR) and 95% confidence interval (CI), as well as P values. All analyses were adjusted for sex. To estimate the degree of disability associated with the core symptoms of GAD or a diagnosis of GAD according to DSM-5 and ICD-10, we used GEE models with linear link functions, also with an exchangeable working correlation matrix structure and a robust estimator of the covariance matrix. All analyses were adjusted for depression (major and minor), sex, age, and medication with beta-blockers (which influences autonomic symptoms). Results were presented with estimates and 95% CI, as well
as P values. P values were considered significant at a level of P < 0.05
(two-tailed) for all analyses. All statistical analyses were performed using SPSS 22.0 for MacOS.
| RESULTS
The nonresponders analyses for our samples showed that the participation rate did not differ between men and women. However, due to oversampling of women (a special study of women's health, the Pro- In the H85 study, there were no data regarding lifetime psychiatric diagnoses and in-patient care during the last year available for nonparticipants. Questions in Table 2 regarding symptoms of GAD were only asked if participants endorsed the gateway symptoms anxiety or worry at any level. In addition, Table 2 shows age-related changes in the prevalence of these symptoms. Among those who endorsed the gateway symptom for anxiety, there were no changes with age. Among those who endorsed the gateway symptom for worries, all associated symptoms decreased with age. Among those with clinical worry and anxiety, there was no decrease in frequency with age (data not shown).
The 1-month prevalence of GAD according to DSM-5 and ICD-10 is shown in Table 3 . The prevalence of ICD10 GAD tended to decrease with age (OR 0.96 per year; CI 0.92-1.00; P = 0.067), while the prevalence of DSM5 GAD remained stable. The prevalence of GAD, irrespective of criteria, was higher in women than in men. The age*sex interaction was not significant for any diagnosis (DSM-5 P = 0.823; ICD P = 0.068), meaning that sex differences were not affected by age. Table 4 shows linear GEE models examining GAF score in relation to age, sex, depression, GAD, anxiety, autonomic arousal, and worry. We found that age, depression, DSM-5 and ICD 10 GAD, anxiety, autonomic arousal, and worry, but not sex, were independently related to lower GAF score. In the multiple regression models, there were no interaction between age and DSM5 GAD or age and anxiety; however, there were interactions with age for ICD10 GAD, autonomic arousal, and subclinical worry. Thus, these symptoms were associated with better social and mental functioning with age.
| DISCUSSION
In line with our hypothesis, symptoms associated with autonomic arousal and muscle tension decreased markedly with age. However, symptoms of worry remained stable or increased. The prevalence of DSM5 GAD did not change with age, while the prevalence of ICD10 GAD tended to decrease. In addition, those with autonomic arousal and those diagnosed with ICD10 GAD had better GAF scores with age, suggesting that these symptoms were associated with better social and mental functioning with increasing age. All these findings suggest that there may be important changes in the expression of anxiety with age.
Our prevalence of DSM5 GAD (3.3-4.3%) is in line with most previous population-based studies using DSM criteria. These studies report point prevalences from 0.8% to 7.3%. 22, 34, 35 Lower figures 34, 36 are seen in studies that employ hierarchical rules and in those that use a fully structured interview (CIDI) 37 rather than a semistructured format. The large variation in prevalence estimates may also be explained by differences in the definition and measurement of anxiety and worry, or real differences between different geographical areas. 38 Only a couple of studies have examined the prevalence of ICD10 GAD in later life, with figures ranging from 1.7% to 3.8%, 34, 39 which are also in line with our prevalence of 2.2% to 5.8%.
Most studies report that the prevalence of GAD, and anxiety disorders in general, decreases with age. 4, 8, 9 In recent years, there has been a debate on whether the decrease in the prevalence of GAD is a true reflection of age or due to methodological factors. Strictly applied diagnostic criteria in older people reveal reduced prevalence rates for GAD according to both DSM and ICD. 40 Others advocate that anxiety is perceived differently in old age, 41 in line with our findings. Some studies in mixed aged populations have compared the prevalence of GAD according to ICD-10 and DSM-IV/5. 34, 36, 42 In line with our study, they found that the prevalence of GAD according to DSM is lower than that of ICD-10, mainly due to definition of clinical significance (Criteria E) and stricter gateway criteria in DSM.
We found that even though the prevalence of the gateway symptoms for DSM5 GAD and ICD10 GAD did not change with age, we found substantial changes in the prevalence of associated symptoms, suggesting age-related changes in the expression of anxiety and worry in those with GAD. Among the symptoms included in GAD, the prevalence of clinically relevant anxiety, autonomic arousal, muscle tension, and irritability decreased with age, while subclinical worry and fatigue increased, and clinical worry, restlessness, concentration difficulties, and sleep disturbances remained stable. It is noteworthy that the ORs and CIs for clinical worry and restlessness indicate that the results may be due to low statistical power. In sum, symptoms associated with "fear" (ie, autonomic arousal and muscle tension) decreased markedly with age, while symptoms associated with worry remained stable or increased. Our finding of reduced prevalence of clinically relevant anxiety with age is in line with other studies. 43, 44 However, there are also studies supporting that anxiety remains stable with age. 45 More surprisingly, we found an increase in the prevalence of worry with age. This is in contrast to most other studies, 11, 46, 47 with some exceptions. 48 The disparity among studies may be due to geographical or cultural differences, as no previous study on worries among older people has been conducted in a Scandinavian population.
In line with previous studies, GAD was associated with increased disability, 2 independent of criteria and presence of major depression.
However, we also found a robust interaction between age and ICD10 GAD in relation to GAF score, suggesting less distress with increasing age. At the symptom level, there was also an interaction between age and autonomic arousal, in relation to GAF score, suggesting that these symptoms also became less severe with increasing age.
In line with previous studies, we found an overall reduction in frequency, and to some extent in severity, of clinical anxiety, autonomic arousal, and muscle tension in relation to age, 44 but the frequency of these symptoms was not affected by age in those with the gateway symptom anxiety.
The prevalence of worry increased with age. Those with subclinical worry reported fewer symptoms and were less bothered by their symptoms with increasing age, which is in line with previous studies reporting that older adults are less prone to pathological worry, and learn to utilize their worries more constructively. 11 However, our findings for clinical worry could not corroborate these results. This may be due to low statistical power or that we capture an increasing number of "healthy worriers" with age.
There may be several explanations for our findings. It has been suggested that emotional control and self-regulation increases with age, 13 resulting in reduced anxiety and reduced "reactivity" to negative emotions, possibly mediated by acceptance of negative emotional experiences. 49 This theory is also supported by studies using functional magnetic resonance imaging (MRI), where older compared with younger adults respond with less activity in amygdala when presented with negative pictures, while maintaining their reactivity to positive information. In addition, we found that the prevalence of GAD according to both ICD-10 and DSM-5 was about twice as high in women as in men between ages 70 and 85 and that this sex difference was not influenced by age. The tendency was rather that differences increased with age, which is in the opposite direction to previous research arguing that sex differences diminish with age. 4 
| Strengths and limitations
The strengths of this study are the population-based study design, the comprehensive examinations performed by experienced psychiatric nurses, and the semistructured instruments allowing for clarifying questions. In addition, the instruments allowed examination of both self-rated and observed symptoms.
There are also some methodological factors and limitations that need to be discussed. First, some subgroups were small leading to low statistical power. Some negative results should therefore be interpreted cautiously. Second, the sample examined between ages 70 and 79 were born in 1930, and those examined at age 85 were born in 1923 to 1924. The two cohorts are thus born 6 to 7 years apart. We can thus not exclude the possibility that the results partly are due to birth cohort differences. However, the cohorts were brought up under similar living circumstances, and the short time interval between them suggests that birth cohort differences should be minimal. Third, the study was conducted over 10 years. Although the samples were examined with almost identical methods and with the last author supervising the examiners, we cannot exclude the possibility that evaluations might have changed over time. Fourth, response rate declined somewhat with increasing age (from 69% at age 70 to 60% at age 85). This might have led to underestimation of psychiatric morbidity with increasing age. Fifth, we did not examine biological factors, and thus, we could not examine the biological determinants of the age-related changes. Sixth, CPRS covers a broad range of psychopathology and includes detailed information regarding description of symptoms and their severity. CPRS has been validated in older populations with good applicability and reliability; however, it has not been validated for different diagnostic criteria. We created algorithms for GAD according to DSM-5 and ICD-10, which have good face validity, and our prevalence rates are in line with other epidemiological studies. Seventh, the use of gateway questions or screening questions may lead to an underestimation of frequency rates. However, it is reasonable to assume that this bias is lower at lower thresholds of the gateway item. Eight, the answers to items from MINI are binary; thus, we lack information on severity and were not able to distinguish between subclinical and clinical symptoms. This could constitute a potential risk of overestimating clinically relevant symptoms. However, by conducting separate regression analyses for binary and for continuous items (from CPRS), we believe that this influence on our findings was minimal. Finally, some persons were taking part both at ages 70, 75, and 79, leading to repeated measurements of these participants. This was necessary in order to retain representative samples at these ages. Hence, all regression analyses were adjusted for repeated measurements.
| Clinical implications
Our results suggest that it is important for clinicians to be aware that the expression of anxiety may change with age and that somatic manifestations of anxiety may not be as common among older compared with younger adults. Furthermore, our study also highlights the lack of consistency between current classification systems of GAD. There needs to be a consensus regarding the essence of GAD and in particular the future inclusion of autonomic arousal symptoms.
| CONCLUSIONS
The prevalence of ICD10 GAD tended to decrease with increasing age while the prevalence of DSM5 GAD remained stable. This difference was partly due to a decreased frequency of severe anxiety and autonomic arousal symptoms, and that worry-associated symptoms increased or remained stable, suggesting changes in the expression of GAD with increasing age.
